Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Ra Capital Healthcare Fund, L.P. investment portfolio
Ra Capital Healthcare Fund, L.P. has made numerous investments in companies such as Enara Bio, Verdiva Bio, and Artios Pharma within the Healthcare & Life Sciences sector.
vc
Portfolio
4
Team
0
Portfolio (4)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Alchemab Therapeutics Ltd Alchemab Therapeutics develops antibody‑based medicines by mining naturally protective antibodies from long‑term disease survivors and other resilient individuals, using deep‑learning and biotechnology platforms to create therapies for cancer, neurodegenerative disorders and infectious diseases. | Healthcare & Life Sciences | London | Confirmed | 2025-11-28 |
| Artios Pharma Limited Artios Pharma Limited develops DNA‑damage‑response‑based cancer therapeutics. Its pipeline includes the ATR inhibitor alnodesertib and the Polθ inhibitor ART6043, targeting hard‑to‑treat solid tumours. | Healthcare & Life Sciences | Cambridge | Confirmed | 2025-12-28 |
Shareholding changes (3)
Ra Capital Healthcare Fund, L.P.'s positions across portfolio companies2025
- SERIES D1 SHARES 0 → 32,687,279
- SERIES A PREFERRED 16,466,485 → 0
- SERIES A-1 PREFERRED 0 → 16,466,485
- SERIES A-3 PREFERRED 0 → 1,897,894